SCHEMBL332929

SCHEMBL332929

Cn1nccc1C(=O)c1ccc(F)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.52
SCN10A Q9Y5Y9 1/20 0.51
P2RX7 Q99572 4/20 0.47
HPGD P15428 1/20 0.43
NPC1 O15118 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
MAPK13 O15264 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332541 0.81 SMO (0.45) HTTSCN10AP2RX7
SCHEMBL2861947 0.76 HPGD (0.61) P2RX7HPGDNPC1SMN1; SMN2RAB9A
SCHEMBL332638 0.75 HTT (0.71) HTTSCN10AHPGDNPC1SMN1; SMN2
SCHEMBL27278396 0.74 HTT (0.67) HTTNPC1SMN1; SMN2HSD17B10CYP1A2
SCHEMBL9744452 0.74 HTT (0.55) HTTSCN10ANPC1SMN1; SMN2HSD17B10
SCHEMBL10400033 0.71 HTT (0.52) HTTSCN10ANPC1SMN1; SMN2HSD17B10
SCHEMBL344480 0.71 HTT (0.60) HTTSCN10ANPC1SMN1; SMN2HSD17B10
SCHEMBL10410003 0.71 HTT (0.49) HTTSCN10AP2RX7NPC1SMN1; SMN2
SCHEMBL10552954 0.70 HTT (0.51) HTTSCN10ANPC1SMN1; SMN2CYP1A2
SCHEMBL4694883 0.70 GAA (0.56) HTTP2RX7HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 US disclosed
EP-2225229-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS Pfizer Inc. (US) 2010-09-08 EP disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 US disclosed
WO-2009069044-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS PFIZER INC. (US) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors ALOX5, ALOX15, CYP3A5 HTT 4673/4885SCN10A 3769/4885P2RX7 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.